Novavax Inc (NVAX)
8.09
+0.03
(+0.37%)
USD |
NASDAQ |
Nov 21, 12:23
Novavax Price: 8.09 for Nov. 21, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 20, 2024 | 8.00 | 8.155 | 7.76 | 8.06 | 3.212M |
| Nov 19, 2024 | 7.80 | 8.10 | 7.650 | 8.00 | 4.254M |
| Nov 18, 2024 | 7.41 | 8.01 | 7.366 | 7.83 | 6.888M |
| Nov 15, 2024 | 7.14 | 7.33 | 6.81 | 7.32 | 9.348M |
| Nov 14, 2024 | 7.80 | 7.94 | 7.17 | 7.22 | 9.033M |
| Nov 13, 2024 | 8.44 | 8.558 | 7.76 | 7.765 | 7.377M |
| Nov 12, 2024 | 8.05 | 8.90 | 7.89 | 8.46 | 10.81M |
| Nov 11, 2024 | 9.89 | 10.39 | 8.90 | 9.01 | 14.66M |
| Nov 08, 2024 | 9.25 | 9.25 | 8.84 | 8.91 | 3.767M |
| Nov 07, 2024 | 9.16 | 9.34 | 8.99 | 9.18 | 3.089M |
| Nov 06, 2024 | 9.06 | 9.27 | 8.425 | 8.96 | 6.501M |
| Nov 05, 2024 | 9.00 | 9.48 | 8.86 | 9.44 | 3.520M |
| Nov 04, 2024 | 9.20 | 9.30 | 8.895 | 9.12 | 4.256M |
| Nov 01, 2024 | 9.69 | 9.87 | 9.29 | 9.35 | 4.439M |
| Oct 31, 2024 | 9.83 | 9.901 | 9.51 | 9.61 | 3.561M |
| Oct 30, 2024 | 10.00 | 10.07 | 9.705 | 9.84 | 4.003M |
| Oct 29, 2024 | 10.24 | 10.63 | 9.875 | 10.07 | 4.533M |
| Oct 28, 2024 | 9.90 | 10.48 | 9.73 | 10.25 | 5.136M |
| Oct 25, 2024 | 9.90 | 9.92 | 9.52 | 9.745 | 5.008M |
| Oct 24, 2024 | 10.00 | 10.16 | 9.85 | 9.92 | 3.542M |
| Oct 23, 2024 | 10.10 | 10.24 | 9.92 | 10.00 | 3.399M |
| Oct 22, 2024 | 10.14 | 10.35 | 10.01 | 10.12 | 3.532M |
| Oct 21, 2024 | 10.10 | 10.22 | 9.90 | 10.14 | 4.790M |
| Oct 18, 2024 | 10.40 | 10.80 | 10.10 | 10.18 | 7.053M |
| Oct 17, 2024 | 10.16 | 10.42 | 9.87 | 10.35 | 9.850M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.75
Minimum
Nov 26 2019
319.93
Maximum
Feb 08 2021
66.04
Average
19.61
Median
Sep 28 2022
Price Benchmarks
| Pfizer Inc | 24.90 |
| Moderna Inc | 36.86 |
| Inovio Pharmaceuticals Inc | 4.21 |
| Baxter International Inc | 32.94 |
| Halozyme Therapeutics Inc | 45.37 |
Price Related Metrics
| PS Ratio | 1.408 |
| Earnings Yield | -28.31% |
| Market Cap | 1.296B |